Skip to main content
Fig. 6 | BMC Biotechnology

Fig. 6

From: Antifungal efficacy of Citrusfusion mediated silver nanoparticles in Candida species

Fig. 6

Antibiofilm potential of CitAgNPs in Candida sp. (a) Tube assay depicting the biofilm formation in control, fluconazole, and CitAgNPs treated tubes. (b) Percentage of biofilm formation of Candida strains upon treatment with CitAgNPs when compared to control and fluconazole treated strains. Error bars represented means ± standard deviation. *Denotes T-test (*P < 0.05, **P < 0.01, ***P < 0.001)

Back to article page